Application of neoadjuvant chemotherapy in treatment of locally advanced cervical cancer / 肿瘤研究与临床

ABSTRACT

Locally advanced cervical cancer (LACC) refers to cervical cancer with large lesions confined to the cervix or only involving pelvic. It is characterized by large tumor volume, difficult local control, difficult operation, easy recurrence and metastasis after operation, and its 5-year overall survival rate is about 50%. Neoadjuvant therapy (NACT) reduces the risk of recurrence and death in patients, reduces the probability of postoperative radiotherapy, and avoids the ovarian dysfunction caused by radiotherapy. However, some studies have shown that NACT is not beneficial to the overall survival of LACC and may even interfere with postoperative pathological diagnosis. Therefore, the clinical application of NACT is still controversial. This article reviews the application of NACT in LACC.